Form 8-K - Current report:
SEC Accession No. 0000950123-07-016733
Filing Date
2007-12-17
Accepted
2007-12-17 16:44:12
Documents
4
Period of Report
2007-12-12
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y44739e8vk.htm 8-K 14407
2 EX-3.2: SECOND AMENDED AND RESTATED BYLAWS y44739exv3w2.htm EX-3.2 60363
3 EX-99.1: PRESS RELEASE y44739exv99w1.htm EX-99.1 10640
4 GRAPHIC y44739y4473901.gif GRAPHIC 8907
  Complete submission text file 0000950123-07-016733.txt   99495
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 071310487
SIC: 2835 In Vitro & In Vivo Diagnostic Substances